A pharmaceutical approach to direct stem cells in the body to promote self-healing

About

The bone marrow is a rich source of stem cells that have the potential to differentiate into various other cell types and has played an important role in therapies for diseases such as leukaemia. Through further research into mechanisms regulating how stem cells exit the bone marrow, Prof Sara Rankin is developing a pharmaceutical approach to direct stem cells in the body to promote self-healing. We have a granted patent in the USA claiming methods of mobilising stem cells for a variety of purposes, such as restoring damaged tissue, accelerating bone repair and optimising stem cell harvesting. Innovations is seeking co-development or licensing partners. Please press “Connect” and we will send you 6 supporting Powerpoint slides on this technology. When contacting us, please quote reference number 4210.

Register for free for full unlimited access to all innovation profiles on LEO

  • Discover articles from some of the world’s brightest minds, or share your thoughts and add one yourself
  • Connect with like-minded individuals and forge valuable relationships and collaboration partners
  • Innovate together, promote your expertise, or showcase your innovations